Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Verona Pharma Plc ADR 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE GBR

www.veronapharma.com Employees: 209 P: 44-20-3283-4200

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 8,748,446
Enterprise Value, $K 8,469,026
Shares Outstanding, K 81,830
Float, K 77,902
% Float 95.20%
Short Interest, K 2,026
Days to Cover 1.52
Short Volume Ratio 0.37
% of Insider Shareholders 4.80%
% of Institutional Shareholders 85.88%

Financials:

Annual Sales, $ 42,280 K
Annual Net Income, $ -173,420 K
Last Quarter Sales, $ 103,140 K
Last Quarter Net Income, $ 11,920 K
EBIT, $ -56,020 K
EBITDA, $ -53,660 K

Growth:

1-Year Return 233.99%
3-Year Return 968.03%
5-Year Return 1,798.93%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 30.32%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.13 on 08/06/25
Next Earnings Date 11/03/25
Earnings Per Share ttm -0.56
EPS Growth vs. Prev Qtr -51.85%
EPS Growth vs. Prev Year 114.77%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VRNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 872.73
Price/Earnings to Growth N/A
Return-on-Equity % -21.12%
Return-on-Assets % -9.07%
Profit Margin % -410.17%
Debt/Equity 0.87
Price/Sales 217.71
Price/Cash Flow N/A
Price/Book 32.71
Book Value/Share 3.27
Interest Coverage -5.93
60-Month Beta 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar